AU731850B2 - Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories - Google Patents
Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories Download PDFInfo
- Publication number
- AU731850B2 AU731850B2 AU48598/97A AU4859897A AU731850B2 AU 731850 B2 AU731850 B2 AU 731850B2 AU 48598/97 A AU48598/97 A AU 48598/97A AU 4859897 A AU4859897 A AU 4859897A AU 731850 B2 AU731850 B2 AU 731850B2
- Authority
- AU
- Australia
- Prior art keywords
- seq
- detection
- species
- dna
- primers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000894007 species Species 0.000 title claims abstract description 175
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 163
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 140
- 230000003321 amplification Effects 0.000 title claims abstract description 139
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 104
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 86
- 238000003745 diagnosis Methods 0.000 title abstract description 8
- 244000052616 bacterial pathogen Species 0.000 title description 21
- 239000003298 DNA probe Substances 0.000 title description 11
- 244000053095 fungal pathogen Species 0.000 title description 11
- 238000001514 detection method Methods 0.000 claims abstract description 138
- 238000012360 testing method Methods 0.000 claims abstract description 71
- 239000000523 sample Substances 0.000 claims abstract description 66
- 238000000034 method Methods 0.000 claims abstract description 60
- 241000191940 Staphylococcus Species 0.000 claims abstract description 43
- 241000894006 Bacteria Species 0.000 claims abstract description 40
- 241000194033 Enterococcus Species 0.000 claims abstract description 39
- 241000194017 Streptococcus Species 0.000 claims abstract description 37
- 230000002538 fungal effect Effects 0.000 claims abstract description 37
- 244000005700 microbiome Species 0.000 claims abstract description 34
- 241001147691 Staphylococcus saprophyticus Species 0.000 claims abstract description 33
- 241000222122 Candida albicans Species 0.000 claims abstract description 29
- 241000588653 Neisseria Species 0.000 claims abstract description 25
- 229940095731 candida albicans Drugs 0.000 claims abstract description 25
- 241000186779 Listeria monocytogenes Species 0.000 claims abstract description 24
- 241000194031 Enterococcus faecium Species 0.000 claims abstract description 23
- 241000588650 Neisseria meningitidis Species 0.000 claims abstract description 20
- 238000009007 Diagnostic Kit Methods 0.000 claims abstract description 19
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims abstract description 18
- 241000193985 Streptococcus agalactiae Species 0.000 claims abstract description 18
- 101150100833 aacC3 gene Proteins 0.000 claims abstract description 14
- 230000000813 microbial effect Effects 0.000 claims abstract description 12
- 101150031494 blaZ gene Proteins 0.000 claims abstract description 9
- 101150037181 vanB gene Proteins 0.000 claims abstract description 9
- 101100119095 Enterococcus faecalis (strain ATCC 700802 / V583) ermB gene Proteins 0.000 claims abstract description 8
- 101150052154 MSRA1 gene Proteins 0.000 claims abstract description 8
- 101150016019 aacA4 gene Proteins 0.000 claims abstract description 8
- 101150014550 aadB gene Proteins 0.000 claims abstract description 8
- 101150016744 ermC gene Proteins 0.000 claims abstract description 8
- 101150021123 msrA gene Proteins 0.000 claims abstract description 8
- 101150114366 msrA2 gene Proteins 0.000 claims abstract description 8
- 101150006794 msrAB gene Proteins 0.000 claims abstract description 8
- 101150109310 msrAB1 gene Proteins 0.000 claims abstract description 8
- 101150052209 msrAB2 gene Proteins 0.000 claims abstract description 8
- 101150114434 vanA gene Proteins 0.000 claims abstract description 8
- 101100102341 Enterococcus gallinarum vanC gene Proteins 0.000 claims abstract description 7
- 101100214700 Acinetobacter baumannii aacC2 gene Proteins 0.000 claims abstract description 6
- 101100214699 Pseudomonas aeruginosa aacC1 gene Proteins 0.000 claims abstract description 6
- 101150025725 ermA gene Proteins 0.000 claims abstract description 6
- 101100422536 Bacillus subtilis (strain 168) satA gene Proteins 0.000 claims abstract description 4
- 101100372548 Enterococcus faecium vatD gene Proteins 0.000 claims abstract description 4
- 238000011002 quantification Methods 0.000 claims abstract 4
- 108020004414 DNA Proteins 0.000 claims description 298
- 150000007523 nucleic acids Chemical class 0.000 claims description 221
- 102000039446 nucleic acids Human genes 0.000 claims description 217
- 108020004707 nucleic acids Proteins 0.000 claims description 217
- 238000003752 polymerase chain reaction Methods 0.000 claims description 97
- 125000003729 nucleotide group Chemical group 0.000 claims description 66
- 239000002773 nucleotide Substances 0.000 claims description 62
- 230000000295 complement effect Effects 0.000 claims description 35
- 108091034117 Oligonucleotide Proteins 0.000 claims description 29
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 17
- 238000011895 specific detection Methods 0.000 claims description 14
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 241000233866 Fungi Species 0.000 claims description 11
- -1 aac6'-lla Proteins 0.000 claims description 10
- 238000005516 engineering process Methods 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 8
- 238000000137 annealing Methods 0.000 claims description 7
- 230000001351 cycling effect Effects 0.000 claims description 7
- 238000004925 denaturation Methods 0.000 claims description 7
- 230000036425 denaturation Effects 0.000 claims description 7
- 238000007834 ligase chain reaction Methods 0.000 claims description 7
- 238000007403 mPCR Methods 0.000 claims description 7
- 206010034133 Pathogen resistance Diseases 0.000 claims description 6
- 238000006073 displacement reaction Methods 0.000 claims description 4
- 238000004362 fungal culture Methods 0.000 claims description 4
- 230000010076 replication Effects 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 3
- 238000007857 nested PCR Methods 0.000 claims description 3
- 238000013518 transcription Methods 0.000 claims description 3
- 230000035897 transcription Effects 0.000 claims description 3
- 101150086253 ermB gene Proteins 0.000 claims 1
- 101150090211 vanC gene Proteins 0.000 claims 1
- 238000003556 assay Methods 0.000 abstract description 40
- 208000015181 infectious disease Diseases 0.000 abstract description 13
- 238000011282 treatment Methods 0.000 abstract description 7
- 238000011309 routine diagnosis Methods 0.000 abstract description 5
- 239000013615 primer Substances 0.000 description 176
- 101150099542 tuf gene Proteins 0.000 description 83
- 101150010742 tuf2 gene Proteins 0.000 description 71
- 101150061352 tufA gene Proteins 0.000 description 66
- 239000012634 fragment Substances 0.000 description 55
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 34
- 238000002944 PCR assay Methods 0.000 description 34
- 229930010555 Inosine Natural products 0.000 description 33
- 229960003786 inosine Drugs 0.000 description 33
- 238000009396 hybridization Methods 0.000 description 26
- 239000002751 oligonucleotide probe Substances 0.000 description 26
- 210000002700 urine Anatomy 0.000 description 23
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 19
- 230000004544 DNA amplification Effects 0.000 description 18
- 244000052769 pathogen Species 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- 238000012163 sequencing technique Methods 0.000 description 17
- 229940115931 listeria monocytogenes Drugs 0.000 description 16
- 101150079601 recA gene Proteins 0.000 description 16
- 238000012408 PCR amplification Methods 0.000 description 15
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 15
- 239000002987 primer (paints) Substances 0.000 description 15
- 230000014670 detection of bacterium Effects 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 12
- 108091093088 Amplicon Proteins 0.000 description 11
- 239000003155 DNA primer Substances 0.000 description 11
- 241000194032 Enterococcus faecalis Species 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 10
- 241000191963 Staphylococcus epidermidis Species 0.000 description 10
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 238000009640 blood culture Methods 0.000 description 10
- 101150071165 tuf1 gene Proteins 0.000 description 10
- 241000191967 Staphylococcus aureus Species 0.000 description 9
- 229940088710 antibiotic agent Drugs 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000002887 multiple sequence alignment Methods 0.000 description 9
- 102000053602 DNA Human genes 0.000 description 8
- 241000607142 Salmonella Species 0.000 description 8
- 241000193996 Streptococcus pyogenes Species 0.000 description 8
- 238000002405 diagnostic procedure Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 241000186216 Corynebacterium Species 0.000 description 7
- 241000193998 Streptococcus pneumoniae Species 0.000 description 7
- 108010006785 Taq Polymerase Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 230000014616 translation Effects 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 102000008153 Peptide Elongation Factor Tu Human genes 0.000 description 6
- 108010049977 Peptide Elongation Factor Tu Proteins 0.000 description 6
- 241000191978 Staphylococcus simulans Species 0.000 description 6
- 241000194024 Streptococcus salivarius Species 0.000 description 6
- 239000011543 agarose gel Substances 0.000 description 6
- 239000003120 macrolide antibiotic agent Substances 0.000 description 6
- 229940041033 macrolides Drugs 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 108020000946 Bacterial DNA Proteins 0.000 description 5
- 241000589513 Burkholderia cepacia Species 0.000 description 5
- 241000588921 Enterobacteriaceae Species 0.000 description 5
- 241000606768 Haemophilus influenzae Species 0.000 description 5
- 241000204051 Mycoplasma genitalium Species 0.000 description 5
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 5
- 241000947836 Pseudomonadaceae Species 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 101150056072 TUFB gene Proteins 0.000 description 5
- 229920004890 Triton X-100 Polymers 0.000 description 5
- 239000013504 Triton X-100 Substances 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000004599 antimicrobial Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000010876 biochemical test Methods 0.000 description 5
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940023064 escherichia coli Drugs 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 241000222173 Candida parapsilosis Species 0.000 description 4
- 241000222178 Candida tropicalis Species 0.000 description 4
- 206010011409 Cross infection Diseases 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 241000588722 Escherichia Species 0.000 description 4
- 241000590002 Helicobacter pylori Species 0.000 description 4
- 241000588621 Moraxella Species 0.000 description 4
- 241000235645 Pichia kudriavzevii Species 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 241000066390 Shewanella putida Species 0.000 description 4
- 241000192087 Staphylococcus hominis Species 0.000 description 4
- 241000122971 Stenotrophomonas Species 0.000 description 4
- 241000194019 Streptococcus mutans Species 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 229940126575 aminoglycoside Drugs 0.000 description 4
- 238000002306 biochemical method Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 229940047650 haemophilus influenzae Drugs 0.000 description 4
- 229940037467 helicobacter pylori Drugs 0.000 description 4
- 244000000010 microbial pathogen Species 0.000 description 4
- 238000009629 microbiological culture Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000002864 sequence alignment Methods 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 208000019206 urinary tract infection Diseases 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241001517050 Corynebacterium accolens Species 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- 241000588914 Enterobacter Species 0.000 description 3
- 241001468179 Enterococcus avium Species 0.000 description 3
- 241000194030 Enterococcus gallinarum Species 0.000 description 3
- 241000207202 Gardnerella Species 0.000 description 3
- 241000207201 Gardnerella vaginalis Species 0.000 description 3
- 206010018612 Gonorrhoea Diseases 0.000 description 3
- 241000201858 Granulicatella adiacens Species 0.000 description 3
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 241000588770 Proteus mirabilis Species 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 241000607715 Serratia marcescens Species 0.000 description 3
- 241000192097 Staphylococcus sciuri Species 0.000 description 3
- 241001446558 Thiomonas delicata Species 0.000 description 3
- 241000589884 Treponema pallidum Species 0.000 description 3
- 241000202898 Ureaplasma Species 0.000 description 3
- 108010059993 Vancomycin Proteins 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 229940055022 candida parapsilosis Drugs 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000005546 dideoxynucleotide Substances 0.000 description 3
- 229940032049 enterococcus faecalis Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940037648 staphylococcus simulans Drugs 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 3
- 102100039217 3-ketoacyl-CoA thiolase, peroxisomal Human genes 0.000 description 2
- 241000201860 Abiotrophia Species 0.000 description 2
- 241000201856 Abiotrophia defectiva Species 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000606125 Bacteroides Species 0.000 description 2
- 241000606124 Bacteroides fragilis Species 0.000 description 2
- 241000588832 Bordetella pertussis Species 0.000 description 2
- 241000589969 Borreliella burgdorferi Species 0.000 description 2
- 241000588923 Citrobacter Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000158523 Corynebacterium striatum Species 0.000 description 2
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001522957 Enterococcus casseliflavus Species 0.000 description 2
- 241000605896 Fibrobacter succinogenes Species 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 241000606790 Haemophilus Species 0.000 description 2
- 241000589989 Helicobacter Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101100153048 Homo sapiens ACAA1 gene Proteins 0.000 description 2
- 241000186805 Listeria innocua Species 0.000 description 2
- 241000186780 Listeria ivanovii Species 0.000 description 2
- 241000186807 Listeria seeligeri Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 241000588675 Neisseria canis Species 0.000 description 2
- 241000588654 Neisseria cinerea Species 0.000 description 2
- 241000588673 Neisseria elongata Species 0.000 description 2
- 241000588651 Neisseria flavescens Species 0.000 description 2
- 241000588659 Neisseria mucosa Species 0.000 description 2
- 241001136170 Neisseria subflava Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 241000606697 Rickettsia prowazekii Species 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- 241001147687 Staphylococcus auricularis Species 0.000 description 2
- 241001147736 Staphylococcus capitis Species 0.000 description 2
- 241001147698 Staphylococcus cohnii Species 0.000 description 2
- 241001134656 Staphylococcus lugdunensis Species 0.000 description 2
- 241000863001 Stigmatella aurantiaca Species 0.000 description 2
- 241000194026 Streptococcus gordonii Species 0.000 description 2
- 241001134658 Streptococcus mitis Species 0.000 description 2
- 241000194025 Streptococcus oralis Species 0.000 description 2
- 241000193991 Streptococcus parasanguinis Species 0.000 description 2
- 241000194023 Streptococcus sanguinis Species 0.000 description 2
- 241000194021 Streptococcus suis Species 0.000 description 2
- 241000194054 Streptococcus uberis Species 0.000 description 2
- 241000194051 Streptococcus vestibularis Species 0.000 description 2
- 201000008754 Tenosynovial giant cell tumor Diseases 0.000 description 2
- 241000222126 [Candida] glabrata Species 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 208000037815 bloodstream infection Diseases 0.000 description 2
- 208000032343 candida glabrata infection Diseases 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- 208000035647 diffuse type tenosynovial giant cell tumor Diseases 0.000 description 2
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000002816 gill Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 102000042567 non-coding RNA Human genes 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 210000004915 pus Anatomy 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 229940046939 rickettsia prowazekii Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001179 synovial fluid Anatomy 0.000 description 2
- 208000002918 testicular germ cell tumor Diseases 0.000 description 2
- 238000005382 thermal cycling Methods 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 241000023308 Acca Species 0.000 description 1
- 241001673062 Achromobacter xylosoxidans Species 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 101710135803 Actin assembly-inducing protein Proteins 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- 241000766754 Agra Species 0.000 description 1
- 241001136782 Alca Species 0.000 description 1
- 241001453371 Alcaligenes faecalis subsp. faecalis Species 0.000 description 1
- 108020004652 Aspartate-Semialdehyde Dehydrogenase Proteins 0.000 description 1
- 241000588732 Atlantibacter hermannii Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 244000177578 Bacterium linens Species 0.000 description 1
- 235000012539 Bacterium linens Nutrition 0.000 description 1
- 241001135228 Bacteroides ovatus Species 0.000 description 1
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 1
- 241000606215 Bacteroides vulgatus Species 0.000 description 1
- 241000588779 Bordetella bronchiseptica Species 0.000 description 1
- 241000588780 Bordetella parapertussis Species 0.000 description 1
- 241000589968 Borrelia Species 0.000 description 1
- OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 241001494522 Citrobacter amalonaticus Species 0.000 description 1
- 241000588917 Citrobacter koseri Species 0.000 description 1
- 241001508000 Corynebacterium bovis Species 0.000 description 1
- 241001134763 Corynebacterium flavescens Species 0.000 description 1
- 241001517043 Corynebacterium genitalium Species 0.000 description 1
- 241001517041 Corynebacterium jeikeium Species 0.000 description 1
- 241001518260 Corynebacterium minutissimum Species 0.000 description 1
- 241001518268 Corynebacterium mycetoides Species 0.000 description 1
- 241001522132 Corynebacterium pseudodiphtheriticum Species 0.000 description 1
- 241001518270 Corynebacterium pseudogenitalium Species 0.000 description 1
- 241000186225 Corynebacterium pseudotuberculosis Species 0.000 description 1
- 241000186246 Corynebacterium renale Species 0.000 description 1
- 241000918600 Corynebacterium ulcerans Species 0.000 description 1
- 241001149409 Cystobasidium minutum Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 241001600125 Delftia acidovorans Species 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 241000178337 Enterococcus dispar Species 0.000 description 1
- 241000520130 Enterococcus durans Species 0.000 description 1
- 241000194029 Enterococcus hirae Species 0.000 description 1
- 241000520134 Enterococcus mundtii Species 0.000 description 1
- 241001235138 Enterococcus raffinosus Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 108020000949 Fungal DNA Proteins 0.000 description 1
- 241000605952 Fusobacterium necrophorum Species 0.000 description 1
- 241001123946 Gaga Species 0.000 description 1
- 241000193789 Gemella Species 0.000 description 1
- 241000606788 Haemophilus haemolyticus Species 0.000 description 1
- 241000588731 Hafnia Species 0.000 description 1
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000222727 Leishmania donovani Species 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 108700016271 Listeria monocytogenes actA Proteins 0.000 description 1
- 241000186814 Listeria welshimeri Species 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 241001185311 Lyticum Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001478292 Moraxella caviae Species 0.000 description 1
- 241001478293 Moraxella cuniculi Species 0.000 description 1
- 241000588771 Morganella <proteobacterium> Species 0.000 description 1
- 101000874093 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) D-alanine-D-alanine ligase Proteins 0.000 description 1
- 241000588678 Neisseria animalis Species 0.000 description 1
- 241000588649 Neisseria lactamica Species 0.000 description 1
- 241000588660 Neisseria polysaccharea Species 0.000 description 1
- 241000588645 Neisseria sicca Species 0.000 description 1
- 241001135519 Neisseria weaveri Species 0.000 description 1
- 241001212279 Neisseriales Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 101710116435 Outer membrane protein Proteins 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 241000588912 Pantoea agglomerans Species 0.000 description 1
- 241000606210 Parabacteroides distasonis Species 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000206590 Peptococcus niger Species 0.000 description 1
- 241000192013 Peptoniphilus asaccharolyticus Species 0.000 description 1
- 241000192035 Peptostreptococcus anaerobius Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000588768 Providencia Species 0.000 description 1
- 241000588777 Providencia rettgeri Species 0.000 description 1
- 241000588778 Providencia stuartii Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 108091036333 Rapid DNA Proteins 0.000 description 1
- 102000001218 Rec A Recombinases Human genes 0.000 description 1
- 108010055016 Rec A Recombinases Proteins 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 241000223254 Rhodotorula mucilaginosa Species 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101100025165 Salmonella typhi murI gene Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000607717 Serratia liquefaciens Species 0.000 description 1
- 241000863430 Shewanella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000219289 Silene Species 0.000 description 1
- 241001279373 Staphylococcus capitis subsp. urealyticus Species 0.000 description 1
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 1
- 241000191980 Staphylococcus intermedius Species 0.000 description 1
- 241000192099 Staphylococcus schleiferi Species 0.000 description 1
- 241000192086 Staphylococcus warneri Species 0.000 description 1
- 241000191973 Staphylococcus xylosus Species 0.000 description 1
- 101000577577 Streptococcus agalactiae Protein B Proteins 0.000 description 1
- 241000194008 Streptococcus anginosus Species 0.000 description 1
- 241001291896 Streptococcus constellatus Species 0.000 description 1
- 241000191981 Streptococcus cristatus Species 0.000 description 1
- 241000194042 Streptococcus dysgalactiae Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000194046 Streptococcus intermedius Species 0.000 description 1
- 241000193987 Streptococcus sobrinus Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- ODMZDQKUHYGKKN-UHFFFAOYSA-N TCA C Natural products CC(CCCC(C)C1=CCC2(C)OC3=C(CC12)C(=O)C(O)CC3)C(=O)O ODMZDQKUHYGKKN-UHFFFAOYSA-N 0.000 description 1
- 241000589584 Terrimonas ferruginea Species 0.000 description 1
- 241001130469 Tila Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000202921 Ureaplasma urealyticum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000605941 Wolinella Species 0.000 description 1
- 241000605939 Wolinella succinogenes Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000025087 Yersinia pseudotuberculosis infectious disease Diseases 0.000 description 1
- WCDYMMVGBZNUGB-ORPFKJIMSA-N [(2r,3r,4s,5r,6r)-6-[[(1r,3r,4r,5r,6r)-4,5-dihydroxy-2,7-dioxabicyclo[4.2.0]octan-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3-hydroxy-2-tetradecyloctadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](COC(=O)C(CCCCCCCCCCCCCC)C(O)CCCCCCCCCCCCCCC)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H]2OC[C@H]2O1 WCDYMMVGBZNUGB-ORPFKJIMSA-N 0.000 description 1
- 241000606836 [Pasteurella] aerogenes Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000002829 antibacterial sensitivity test Methods 0.000 description 1
- 238000011203 antimicrobial therapy Methods 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 101150107204 asd gene Proteins 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 208000033847 bacterial urinary tract infection Diseases 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000002815 broth microdilution Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000010244 detection of fungus Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(IV) oxide Inorganic materials O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- ADKOXSOCTOWDOP-UHFFFAOYSA-L magnesium;aluminum;dihydroxide;trihydrate Chemical compound O.O.O.[OH-].[OH-].[Mg+2].[Al] ADKOXSOCTOWDOP-UHFFFAOYSA-L 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000005497 microtitration Methods 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940074571 peptostreptococcus anaerobius Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 238000013492 plasmid preparation Methods 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000011451 sequencing strategy Methods 0.000 description 1
- 229940098362 serratia marcescens Drugs 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 108010032807 vancomycin B Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/26—Klebsiella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Communicable Diseases (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU54221/01A AU775763B2 (en) | 1996-11-04 | 2001-07-04 | Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/743637 | 1996-11-04 | ||
| US08/743,637 US5994066A (en) | 1995-09-11 | 1996-11-04 | Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| PCT/CA1997/000829 WO1998020157A2 (en) | 1996-11-04 | 1997-11-04 | Species-specific, genus-specific and universal dna probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU54221/01A Division AU775763B2 (en) | 1996-11-04 | 2001-07-04 | Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4859897A AU4859897A (en) | 1998-05-29 |
| AU731850B2 true AU731850B2 (en) | 2001-04-05 |
Family
ID=24989560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU48598/97A Expired AU731850B2 (en) | 1996-11-04 | 1997-11-04 | Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5994066A (enExample) |
| EP (8) | EP2128268B1 (enExample) |
| JP (3) | JP2001504330A (enExample) |
| CN (1) | CN1248295A (enExample) |
| AT (2) | ATE434669T1 (enExample) |
| AU (1) | AU731850B2 (enExample) |
| BR (1) | BR9713494A (enExample) |
| CA (4) | CA2789369C (enExample) |
| DE (1) | DE69739473D1 (enExample) |
| DK (1) | DK0943009T3 (enExample) |
| ES (1) | ES2329202T3 (enExample) |
| NO (1) | NO991976L (enExample) |
| NZ (1) | NZ335548A (enExample) |
| WO (1) | WO1998020157A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9777335B2 (en) | 2001-06-04 | 2017-10-03 | Geneohm Sciences Canada Inc. | Method for the detection and identification of methicillin-resistant Staphylococcus aureus |
| US11834720B2 (en) | 2005-10-11 | 2023-12-05 | Geneohm Sciences, Inc. | Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx |
Families Citing this family (187)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020055101A1 (en) | 1995-09-11 | 2002-05-09 | Michel G. Bergeron | Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| US6905670B2 (en) | 1995-03-28 | 2005-06-14 | The General Hospital Corporation | Methods of screening compounds useful for prevention of infection or pathogenicity |
| ES2288760T3 (es) | 1996-04-25 | 2008-01-16 | Bioarray Solutions Ltd. | Ensamblaje electrocinetico controlado por luz de particulas proximas a superficies. |
| US20030049636A1 (en) * | 1999-05-03 | 2003-03-13 | Bergeron Michel G. | Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| US20100267012A1 (en) | 1997-11-04 | 2010-10-21 | Bergeron Michel G | Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| US6558901B1 (en) * | 1997-05-02 | 2003-05-06 | Biomerieux Vitek | Nucleic acid assays |
| US6570001B1 (en) * | 1997-06-20 | 2003-05-27 | Institut Pasteur | Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| DE19731292A1 (de) * | 1997-07-21 | 1999-01-28 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Nucleinsäuremolekül, Kit und Verwendung |
| US7060458B1 (en) | 1997-08-14 | 2006-06-13 | Wyeth | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| JP2002505849A (ja) | 1997-11-25 | 2002-02-26 | ザ ジュネラル ホスピタル コーポレーション | ビルレンス関連核酸配列およびその使用 |
| EP1049809B1 (en) | 1998-01-23 | 2006-10-25 | bioMerieux B.V. | EF-Tu mRNA AS A MARKER FOR VIABILITY OF BACTERIA |
| US6468743B1 (en) * | 1998-05-18 | 2002-10-22 | Conagra Grocery Products Company | PCR techniques for detecting microbial contaminants in foodstuffs |
| ES2189459T3 (es) | 1998-05-22 | 2003-07-01 | Creatogen Ag | Deteccion de resistencias a antibioticos en microorganismos. |
| WO2000014274A1 (en) * | 1998-09-03 | 2000-03-16 | The University Of British Columbia | Method for the identification and speciation of bacteria of the burkholderia cepacia complex |
| US6242223B1 (en) * | 1998-09-28 | 2001-06-05 | Creighton University | Primers for use in detecting beta-lactamases |
| US6451556B1 (en) * | 1998-12-21 | 2002-09-17 | Smithkline Beecham Corporation | EF-Tu |
| GB9904804D0 (en) * | 1999-03-02 | 1999-04-28 | King S College London | Identification of bacteria |
| EP2281834B1 (en) * | 1999-04-09 | 2015-03-04 | Zoetis P&U LLC | Attenuated Pasteurellaceae bacterium having a mutation in a virulence gene |
| US6605709B1 (en) | 1999-04-09 | 2003-08-12 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics |
| US6066461A (en) * | 1999-04-12 | 2000-05-23 | Becton Dickinson And Company | Amplification and detection of Campylobacter jejuni and Campylobacter coli |
| US6821770B1 (en) * | 1999-05-03 | 2004-11-23 | Gen-Probe Incorporated | Polynucleotide matrix-based method of identifying microorganisms |
| EP1246935B1 (en) | 1999-09-28 | 2013-08-14 | Geneohm Sciences Canada Inc. | Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| WO2001036683A2 (en) * | 1999-11-16 | 2001-05-25 | Apollo Biotechnology, Inc. | Method for rapid and accurate identification of microorganisms |
| US20030134293A1 (en) * | 1999-11-16 | 2003-07-17 | Zhiping Liu | Method for rapid and accurate identification of microorganisms |
| EP1118677A1 (en) * | 2000-01-17 | 2001-07-25 | Novartis AG | Oligonucleotides useful in identifying fungicide resistant plant pathogenic fungi |
| US7955794B2 (en) | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
| US8076063B2 (en) | 2000-02-07 | 2011-12-13 | Illumina, Inc. | Multiplexed methylation detection methods |
| US7611869B2 (en) | 2000-02-07 | 2009-11-03 | Illumina, Inc. | Multiplexed methylation detection methods |
| US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
| US7112716B2 (en) | 2000-04-06 | 2006-09-26 | The General Hospital Corporation | Methods for screening and identifying host pathogen defense genes |
| US20020102678A1 (en) * | 2000-04-14 | 2002-08-01 | Solh Nevine El | Staphylococcal gene, vgaC, conferring resistance to streptogramin A and related compounds |
| EP1512756B1 (en) * | 2000-05-29 | 2008-03-19 | Tosoh Corporation | Methods for detection mecA gene of methicillin-resistant Staphylococcus Aureus |
| US9709559B2 (en) | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
| DE60117556T2 (de) | 2000-06-21 | 2006-11-02 | Bioarray Solutions Ltd. | Multianalytische molekularanalyse durch verwendung anwendungsspezifischer zufallspartikelarrays |
| US6261785B1 (en) | 2000-07-27 | 2001-07-17 | Becton, Dickinson And Company | Amplification and detection of Bordetella pertussis |
| US20040005555A1 (en) * | 2000-08-31 | 2004-01-08 | Rothman Richard E. | Molecular diagnosis of bactermia |
| GB0022017D0 (en) * | 2000-09-08 | 2000-10-25 | Univ Dundee | Cell assays |
| US20020086313A1 (en) * | 2000-09-25 | 2002-07-04 | Kilbane John J. | Application of bioinformatics for direct study of unculturable microorganisms |
| US7226739B2 (en) | 2001-03-02 | 2007-06-05 | Isis Pharmaceuticals, Inc | Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations |
| US20030027135A1 (en) | 2001-03-02 | 2003-02-06 | Ecker David J. | Method for rapid detection and identification of bioagents |
| US7718354B2 (en) | 2001-03-02 | 2010-05-18 | Ibis Biosciences, Inc. | Methods for rapid identification of pathogens in humans and animals |
| AT410444B (de) * | 2001-03-02 | 2003-04-25 | Oesterr Forsch Seibersdorf | Verfahren zur detektion von nukleinsäuremolekülen |
| AU2013231102B2 (en) * | 2001-03-02 | 2016-04-28 | Ibis Biosciences, Inc. | Methods for rapid identification of pathogens in humans and animals |
| US7666588B2 (en) | 2001-03-02 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
| US20040121310A1 (en) * | 2002-12-18 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents in forensic studies |
| US20040121314A1 (en) * | 2002-12-06 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents in containers |
| US20040121311A1 (en) | 2002-12-06 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents in livestock |
| US7052837B2 (en) * | 2001-03-13 | 2006-05-30 | The Board Of Trustees Of The University Of Arkansas | Histoplasma capsulatum catalase sequences and their use in the detection of Histoplamsa capsulatum and histoplasmosis |
| DE10124342A1 (de) * | 2001-05-18 | 2002-11-28 | Biotecon Diagnostics Gmbh | Verfahren zum Nachweis von Mikroorganismen der Spezies Yersinia pestis/Yersinia pseudotuberculosis und/oder zur Differzierung zwischen Yersinia pestis und Yersinia pseudotuberculosis |
| US7262063B2 (en) | 2001-06-21 | 2007-08-28 | Bio Array Solutions, Ltd. | Directed assembly of functional heterostructures |
| NZ530343A (en) * | 2001-06-22 | 2007-01-26 | Marshfield Clinic | Methods and oligonucleotides for the detection of E. coli 0157:H7 |
| US8073627B2 (en) | 2001-06-26 | 2011-12-06 | Ibis Biosciences, Inc. | System for indentification of pathogens |
| US7217510B2 (en) | 2001-06-26 | 2007-05-15 | Isis Pharmaceuticals, Inc. | Methods for providing bacterial bioagent characterizing information |
| AU2002354838B2 (en) * | 2001-07-19 | 2007-11-29 | Infectio Diagnostic (I.D.I.) Inc. | Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
| FR2829148B1 (fr) * | 2001-09-06 | 2004-10-15 | Univ Aix Marseille Ii | Identification moleculaire des bacteries du genre staphylococcus |
| CA2741049C (en) | 2001-10-15 | 2019-02-05 | Bioarray Solutions, Ltd. | Multiplexed analysis of polymorphic loci by probe elongation-mediated detection |
| US20040002080A1 (en) * | 2001-12-14 | 2004-01-01 | Creighton University | Primers for use in detecting beta-lactamases |
| AU2002366391A1 (en) * | 2001-12-19 | 2003-06-30 | Quantibact A/S | A method and a kit for determination of a microbial count |
| ES2223216B1 (es) * | 2002-03-11 | 2006-04-16 | Universidad De Sevilla | Metodo para la deteccion e identificacion rapida de salmonella spp. mediante la reaccion en cadena de la polimerasa en tiempo real. |
| US6946267B2 (en) * | 2002-03-13 | 2005-09-20 | Dr. Chip Biotechnology Inc. | Method for detecting Staphylococcus aureus |
| US7045291B2 (en) * | 2002-05-17 | 2006-05-16 | Creighton University | Multiplex PCR for the detection of AmpC beta-lactamase genes |
| US7108976B2 (en) * | 2002-06-17 | 2006-09-19 | Affymetrix, Inc. | Complexity management of genomic DNA by locus specific amplification |
| DE10244456A1 (de) * | 2002-09-24 | 2004-04-15 | Hain Lifescience Gmbh | Verfahren zum Nachweis und Differenzierung von Bakterien |
| AU2003298655A1 (en) | 2002-11-15 | 2004-06-15 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
| US7217519B1 (en) | 2002-11-21 | 2007-05-15 | The Board Of Trustees Of The University Of Arkansas | Histoplasma capsulatum chitin synthase sequences and their use for detection of Histoplasma capsulatum and histoplasmosis |
| CA2508726A1 (en) | 2002-12-06 | 2004-07-22 | Isis Pharmaceuticals, Inc. | Methods for rapid identification of pathogens in humans and animals |
| US7718402B2 (en) | 2002-12-13 | 2010-05-18 | Geneohm Sciences Canada Inc. | Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection |
| US8046171B2 (en) | 2003-04-18 | 2011-10-25 | Ibis Biosciences, Inc. | Methods and apparatus for genetic evaluation |
| US8057993B2 (en) | 2003-04-26 | 2011-11-15 | Ibis Biosciences, Inc. | Methods for identification of coronaviruses |
| US7964343B2 (en) | 2003-05-13 | 2011-06-21 | Ibis Biosciences, Inc. | Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US8158354B2 (en) | 2003-05-13 | 2012-04-17 | Ibis Biosciences, Inc. | Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| CA2525540A1 (en) * | 2003-05-30 | 2004-12-09 | Intercell Ag | Enterococcus antigens |
| CN1296488C (zh) * | 2003-06-19 | 2007-01-24 | 中国药品生物制品检定所 | 药品中主要病原微生物的检测 |
| DE10339609A1 (de) * | 2003-08-28 | 2005-03-24 | Forschungszentrum Karlsruhe Gmbh | Oligonukleotid, Verfahren und System zur Detektion von Antibiotikaresistenz-vermittelnden Genen in Mikroorganismen mittels der Echtzeit-PCR |
| ATE419394T1 (de) | 2003-09-04 | 2009-01-15 | Human Genetic Signatures Pty | Nukleinsäurenachweistest |
| US20070248954A1 (en) * | 2003-09-10 | 2007-10-25 | Creighton University | Primers for Use in Detecting Beta-Lactamases |
| US8288523B2 (en) | 2003-09-11 | 2012-10-16 | Ibis Biosciences, Inc. | Compositions for use in identification of bacteria |
| US8546082B2 (en) | 2003-09-11 | 2013-10-01 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US8097416B2 (en) | 2003-09-11 | 2012-01-17 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US20050058985A1 (en) * | 2003-09-12 | 2005-03-17 | Dodgson Kirsty Jane | Method and kit for identifying vancomycin-resistant enterococcus |
| US7927796B2 (en) | 2003-09-18 | 2011-04-19 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
| ES2375962T3 (es) | 2003-09-22 | 2012-03-07 | Bioarray Solutions Ltd | Polielectrolito inmovilizado en superficie con múltiples grupos funcionales capaces de unirse covalentemente a biomoléculas. |
| NZ547492A (en) | 2003-10-28 | 2009-12-24 | Bioarray Solutions Ltd | Optimization of gene expression analysis using immobilized capture probes of different lengths and densities |
| NZ547495A (en) | 2003-10-29 | 2008-05-30 | Bioarray Solutions Ltd | Multiplexed nucleic acid analysis by fragmentation of double-stranded DNA |
| US8163895B2 (en) | 2003-12-05 | 2012-04-24 | Ibis Biosciences, Inc. | Compositions for use in identification of orthopoxviruses |
| US7666592B2 (en) | 2004-02-18 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for concurrent identification and quantification of an unknown bioagent |
| US8119336B2 (en) | 2004-03-03 | 2012-02-21 | Ibis Biosciences, Inc. | Compositions for use in identification of alphaviruses |
| US8168777B2 (en) | 2004-04-29 | 2012-05-01 | Human Genetic Signatures Pty. Ltd. | Bisulphite reagent treatment of nucleic acid |
| WO2005113826A1 (en) * | 2004-05-20 | 2005-12-01 | Bioarray Solutions Ltd. | Genotyping of multiple loci with pcr for different loci amplification at different temperatures |
| WO2005117270A2 (en) | 2004-05-24 | 2005-12-08 | Isis Pharmaceuticals, Inc. | Mass spectrometry with selective ion filtration by digital thresholding |
| US20050266411A1 (en) | 2004-05-25 | 2005-12-01 | Hofstadler Steven A | Methods for rapid forensic analysis of mitochondrial DNA |
| CN100374577C (zh) * | 2004-06-25 | 2008-03-12 | 吴秉铨 | 用于检测b族链球菌特有序列的引物、短柄圆环探针、试剂盒及方法 |
| US7811753B2 (en) | 2004-07-14 | 2010-10-12 | Ibis Biosciences, Inc. | Methods for repairing degraded DNA |
| CA2572178A1 (en) * | 2004-07-26 | 2006-03-16 | Nanosphere, Inc. | Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture |
| US7848889B2 (en) | 2004-08-02 | 2010-12-07 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
| WO2006012727A1 (en) * | 2004-08-02 | 2006-02-09 | Infectio Recherche Inc. | Capture probe design for efficient hybridisation |
| US7309589B2 (en) | 2004-08-20 | 2007-12-18 | Vironix Llc | Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing |
| DK1794173T3 (da) | 2004-09-10 | 2010-10-25 | Human Genetic Signatures Pty | Amplifikationsblokker indeholdende interkalaterende nukleinsyrer (INA) indeholdende interkalaterende pseudonukleotider (IPN) |
| FR2875240B1 (fr) * | 2004-09-16 | 2006-11-17 | Biomerieux Sa | Procede de detection de streptococcus agalactiae en utilisant l'activite alpha-glucosidase |
| NZ555620A (en) * | 2004-12-03 | 2008-08-29 | Human Genetic Signatures Pty | Methods for simplifying microbial nucleic acids by chemical modification of cytosines |
| WO2006088860A2 (en) * | 2005-02-14 | 2006-08-24 | Beattie Kenneth L | Universal fingerprinting chips and uses thereof |
| US8182992B2 (en) | 2005-03-03 | 2012-05-22 | Ibis Biosciences, Inc. | Compositions for use in identification of adventitious viruses |
| US8084207B2 (en) | 2005-03-03 | 2011-12-27 | Ibis Bioscience, Inc. | Compositions for use in identification of papillomavirus |
| US20060210998A1 (en) * | 2005-03-18 | 2006-09-21 | Christiane Kettlitz | Determination of antibiotic resistance in staphylococcus aureus |
| US7498136B2 (en) * | 2005-03-18 | 2009-03-03 | Eragen Biosciences, Inc. | Methods for detecting multiple species and subspecies of Neisseria |
| US20060210999A1 (en) * | 2005-03-18 | 2006-09-21 | Verena Grimm | Microarray and method for genotyping SHV beta lactamases |
| US20060246463A1 (en) * | 2005-04-20 | 2006-11-02 | Vevea Dirk N | Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes |
| US20060240442A1 (en) * | 2005-04-20 | 2006-10-26 | Vevea Dirk N | Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes |
| JP2008541705A (ja) | 2005-05-26 | 2008-11-27 | ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド | 非標準塩基を含むプライマーを使用する等温鎖置換増幅 |
| US8486629B2 (en) | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
| EP1904655A2 (en) | 2005-07-21 | 2008-04-02 | Isis Pharmaceuticals, Inc. | Methods for rapid identification and quantitation of nucleic acid variants |
| US8343738B2 (en) | 2005-09-14 | 2013-01-01 | Human Genetic Signatures Pty. Ltd. | Assay for screening for potential cervical cancer |
| CN1814797B (zh) * | 2005-12-02 | 2012-09-19 | 浙江大学 | 用于鉴定临床菌血症28种常见致病菌的特异性探针 |
| WO2007118222A2 (en) | 2006-04-06 | 2007-10-18 | Ibis Biosciences, INC | Compositions for the use in identification of fungi |
| KR100741375B1 (ko) | 2006-07-24 | 2007-07-27 | 대한민국 | 기질확장형 β-락타마제의 신속분류를 위한 멀티플렉스ＰＣＲ 기법 및 이를 위한 ＰＣＲ 프라이머 |
| AT504194B1 (de) * | 2006-09-07 | 2008-07-15 | Oesterr Rotes Kreuz | Bakteriennachweis |
| CA2663029C (en) | 2006-09-14 | 2016-07-19 | Ibis Biosciences, Inc. | Targeted whole genome amplification method for identification of pathogens |
| US8871471B2 (en) | 2007-02-23 | 2014-10-28 | Ibis Biosciences, Inc. | Methods for rapid forensic DNA analysis |
| EP2137523A1 (en) | 2007-04-04 | 2009-12-30 | Network Biosystems, Inc. | Plastic microfluidic separation and detection platforms |
| US8017337B2 (en) | 2007-04-19 | 2011-09-13 | Molecular Detection, Inc. | Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria |
| US9096849B2 (en) * | 2007-05-21 | 2015-08-04 | The United States Of America, As Represented By The Secretary Of The Navy | Solid phase for capture of nucleic acids |
| WO2008151023A2 (en) | 2007-06-01 | 2008-12-11 | Ibis Biosciences, Inc. | Methods and compositions for multiple displacement amplification of nucleic acids |
| US20090305252A1 (en) * | 2007-06-05 | 2009-12-10 | Yihong Li | Methods and species-specific primers for detection and quantification of Streptococcus mutans and Streptococcus sanguinis in mixed bacterial samples |
| US7888075B2 (en) * | 2007-07-31 | 2011-02-15 | Quest Diagnostics Investments Incorporated | Detection of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in biological samples |
| FR2922896B1 (fr) * | 2007-10-30 | 2011-04-15 | Biomerieux Sa | Test biochimique pour confirmer la presence de l.monocytogenes |
| CA2706740C (en) | 2007-11-27 | 2017-01-17 | Human Genetic Signatures Pty Ltd | Enzymes for amplification and copying bisulphite modified nucleic acids |
| FI20075976A0 (fi) | 2007-12-31 | 2007-12-31 | Finnzymes Oy | Menetelmät ja oligonukleotidit utaretulehdusta aiheuttavien bakteerien osoittamiseksi |
| EP2349549B1 (en) | 2008-09-16 | 2012-07-18 | Ibis Biosciences, Inc. | Mixing cartridges, mixing stations, and related kits, and system |
| EP2347254A2 (en) | 2008-09-16 | 2011-07-27 | Ibis Biosciences, Inc. | Sample processing units, systems, and related methods |
| US8534447B2 (en) | 2008-09-16 | 2013-09-17 | Ibis Biosciences, Inc. | Microplate handling systems and related computer program products and methods |
| US20100112643A1 (en) * | 2008-11-04 | 2010-05-06 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Method for direct capture of ribonucleic acid |
| GB0901707D0 (en) * | 2009-02-03 | 2009-03-11 | Q Chip Ltd | Assay products, devices and method |
| EP2396803A4 (en) | 2009-02-12 | 2016-10-26 | Ibis Biosciences Inc | IONIZATION PROBE ASSEMBLIES |
| JP5600880B2 (ja) * | 2009-03-03 | 2014-10-08 | 東洋紡株式会社 | 改良された増幅試薬 |
| WO2010104798A1 (en) | 2009-03-08 | 2010-09-16 | Ibis Biosciences, Inc. | Bioagent detection methods |
| JP5593037B2 (ja) * | 2009-03-12 | 2014-09-17 | 東洋水産株式会社 | 細菌測定用プライマーおよび細菌測定方法 |
| WO2010114842A1 (en) | 2009-03-30 | 2010-10-07 | Ibis Biosciences, Inc. | Bioagent detection systems, devices, and methods |
| EP2443254A2 (en) | 2009-06-15 | 2012-04-25 | NetBio, Inc. | Improved methods for forensic dna quantitation |
| WO2011008971A1 (en) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Lift and mount apparatus |
| WO2011008972A1 (en) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Systems for bioagent identification |
| US9416409B2 (en) | 2009-07-31 | 2016-08-16 | Ibis Biosciences, Inc. | Capture primers and capture sequence linked solid supports for molecular diagnostic tests |
| WO2011017656A2 (en) | 2009-08-06 | 2011-02-10 | Ibis Biosciences, Inc. | Non-mass determined base compositions for nucleic acid detection |
| US20110200995A1 (en) * | 2009-09-04 | 2011-08-18 | Intelligent Medical Devices, Inc. | Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci |
| EP3225695A1 (en) | 2009-10-15 | 2017-10-04 | Ibis Biosciences, Inc. | Multiple displacement amplification |
| US9758840B2 (en) | 2010-03-14 | 2017-09-12 | Ibis Biosciences, Inc. | Parasite detection via endosymbiont detection |
| JP2011223940A (ja) * | 2010-04-21 | 2011-11-10 | Asahi Breweries Ltd | 偽陰性を排除するｐｃｒ検査方法およびそれに使用するプライマー |
| US8877909B2 (en) | 2011-04-04 | 2014-11-04 | Intelligent Medical Devices, Inc. | Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group B Streptococcus |
| EP3447147A1 (en) | 2011-05-12 | 2019-02-27 | NetBio, Inc. | Methods and compositions for rapid multiplex amplification of str loci |
| NZ622418A (en) | 2011-09-07 | 2014-12-24 | Human Genetic Signatures Pty | Molecular detection assay |
| WO2013052124A2 (en) * | 2011-10-03 | 2013-04-11 | University Of Florida Research Foundation, Inc. | Rapid and reliable detection of infectious agents |
| US10167520B2 (en) | 2011-12-06 | 2019-01-01 | Scot E. Dowd | Universal or broad range assays and multi-tag sample specific diagnostic process using non-optical sequencing |
| JP6976167B2 (ja) | 2014-06-13 | 2021-12-08 | キュー−リネア エービー | 微生物の検出及び特徴付け方法 |
| MX383495B (es) * | 2014-09-04 | 2025-03-14 | Labrador Diagnostics Llc | Prueba de resistencia a patógenos y antimicrobiana |
| CN104313167A (zh) * | 2014-10-31 | 2015-01-28 | 广东医学院 | 快速鉴定b族链球菌兼检测其耐药性的引物及方法及引物应用 |
| GB201507026D0 (en) | 2015-04-24 | 2015-06-10 | Linea Ab Q | Medical sample transportation container |
| WO2017044880A1 (en) * | 2015-09-09 | 2017-03-16 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage |
| CN105936931A (zh) * | 2016-04-15 | 2016-09-14 | 山东畜牧兽医职业学院 | 一种荧光定量pcr检测养禽场肠杆菌科耐药基因的试剂盒及其检测方法 |
| GB2554767A (en) | 2016-04-21 | 2018-04-11 | Q Linea Ab | Detecting and characterising a microorganism |
| CN116270991A (zh) * | 2016-11-01 | 2023-06-23 | 合成生物制品有限公司 | 用于减弱抗生素抗性的方法和组合物 |
| CN106480219A (zh) * | 2016-12-15 | 2017-03-08 | 贵州大学 | 一种畜禽葡萄球菌大环内酯类药物耐药基因多重pcr检测试剂盒及使用方法 |
| CN108456738B (zh) * | 2017-05-15 | 2021-08-31 | 中国农业科学院兰州兽医研究所 | 一种TaqMan实时荧光定量PCR检测腐生葡萄球菌的方法 |
| CN110129459B (zh) * | 2018-02-05 | 2023-02-24 | 首都医科大学附属北京朝阳医院 | 一种用于检测眼内液中5种革兰氏阳性细菌的lamp引物组合及应用 |
| CN108624704B (zh) * | 2018-06-22 | 2021-08-10 | 上海孚清生物科技有限公司 | 一种荧光定量pcr探针技术联合检测沙眼衣原体、淋球菌、生殖道支原体的方法和试剂盒 |
| EP3846940A4 (en) * | 2018-09-03 | 2022-07-27 | Visby Medical, Inc. | DEVICES AND METHODS FOR TESTING ANTIBIOTIC SUSCEPTIBILITY |
| CN109402277A (zh) * | 2018-12-13 | 2019-03-01 | 博奥生物集团有限公司 | 用于快速检测粪肠球菌和屎肠球菌的lamp引物组合及应用 |
| CN111693657A (zh) * | 2019-03-15 | 2020-09-22 | 烟台欣和企业食品有限公司 | 评估调味品防腐能力的方法 |
| CA3144266A1 (en) * | 2019-06-19 | 2020-12-24 | T2 Biosystems, Inc. | Methods and compositions for comprehensive and high sensitivity detection of pathogens and drug resistance markers |
| CN110257540A (zh) * | 2019-07-23 | 2019-09-20 | 中国疾病预防控制中心传染病预防控制所 | 检测变形杆菌属及奇异变形杆菌的pcr引物、引物组、探针及其试剂盒和检测方法 |
| US11441167B2 (en) * | 2019-11-20 | 2022-09-13 | Roche Molecular Systems, Inc. | Compositions and methods for rapid identification and phenotypic antimicrobial susceptibility testing of bacteria and fungi |
| CN110951895B (zh) * | 2019-12-24 | 2021-03-23 | 重庆市畜牧科学院 | 检测和区分奇异变形杆菌、普通变形杆菌和潘氏变形杆菌的系统和方法 |
| CN111705118B (zh) * | 2020-06-23 | 2023-01-10 | 宁夏医科大学总医院 | 一种基于靶基因高通量测序的血流感染检测试剂盒 |
| KR102781683B1 (ko) * | 2021-01-15 | 2025-03-17 | 주식회사 인트론바이오테크놀로지 | 엔테로코쿠스 패슘(Enterococcus faecium) 균에 대하여 용균활성을 갖는 항균단백질 EFL200 |
| EP4294521A4 (en) * | 2021-02-17 | 2025-01-08 | Cap Diagnostics, LLC, DBA Pathnostics | Methods and systems for determining suitability of compositions for inhibiting growth of polymicrobial samples |
| CN112863606B (zh) * | 2021-03-08 | 2022-07-26 | 杭州微数生物科技有限公司 | 细菌鉴定和分型分析基因组数据库及鉴定和分型分析方法 |
| US20240285726A1 (en) | 2021-06-02 | 2024-08-29 | Syngulon S.A. | Bacteriocin for new application |
| US20240197820A1 (en) | 2021-06-02 | 2024-06-20 | Syngulon S.A. | Bacteriocin for new application |
| CN113493847B (zh) * | 2021-06-24 | 2022-04-19 | 北京工业大学 | 基于PMA高通量测序和PICRUSt的抗生素抗性基因及潜在宿主细菌的鉴定方法 |
| CN113481310B (zh) * | 2021-07-27 | 2023-05-05 | 河北农业大学 | 一种检测生姜腐烂病病原的lamp引物组、lamp试剂盒及其应用 |
| CN113817810A (zh) * | 2021-08-09 | 2021-12-21 | 宁波大学 | 一种检测发酵乳中乳酸菌的新型qPCR方法 |
| WO2023049273A1 (en) * | 2021-09-22 | 2023-03-30 | Biomedit, Llc | Methods for preserving healthy intestinal microbiome during growth promoter administration |
| WO2023081770A1 (en) * | 2021-11-03 | 2023-05-11 | T2 Biosystems, Inc. | Methods and systems for amplification and detection in biological samples |
| CN114214399A (zh) * | 2021-12-17 | 2022-03-22 | 山东博弘基因科技有限公司 | 一种解脲脲原体pcr检测试剂盒 |
| WO2024036158A1 (en) * | 2022-08-08 | 2024-02-15 | North Carolina State University | Methods and compositions for detecting the fungal pathogen ceratocystis fimbriata |
| CN116287330B (zh) * | 2022-12-30 | 2023-12-05 | 中国科学院生态环境研究中心 | 一种可检测多种毒力基因的高通量实时荧光定量pcr芯片及其检测方法 |
| CN119506450B (zh) * | 2025-01-21 | 2025-05-06 | 中国医学科学院北京协和医院 | 一种同时检测血流感染5种病原体的组合物 |
| CN119662873B (zh) * | 2025-02-21 | 2025-06-13 | 国科大杭州高等研究院 | 一种检测弗格森埃希菌的靶基因、引物及方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2699539A1 (fr) * | 1992-12-18 | 1994-06-24 | Pasteur Institut | Protéine conférant une résistance de type inductible, à des glycopeptides, notamment chez des bactéries à gram-positif. Séquence de nucléotides codant pour cette protéine. |
| WO1996008582A2 (en) * | 1994-09-12 | 1996-03-21 | Bergeron Michel G | Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL71715A0 (en) * | 1983-08-05 | 1984-09-30 | Miles Lab | Method,gene probes and test kit for detecting bacteria by nucleic acid hybridization |
| FR2567541B1 (fr) * | 1984-07-13 | 1987-02-06 | Pasteur Institut | Sonde d'adn et procede pour la detection de " shigelles " et des souches entero-invasives de escherichia coli |
| FR2584419B1 (fr) * | 1985-07-08 | 1987-11-13 | Pasteur Institut | Sonde et procede pour la detection de facteurs de resistance a l'erythromycine dans des cultures cellulaires, notamment bacteriennes |
| FR2599743B1 (fr) * | 1986-06-10 | 1988-09-30 | Pasteur Institut | Fragment d'adn comprenant au moins une partie d'un gene de resistance a l'erythromycine, son procede d'obtention et ses applications biochimiques |
| WO1988000618A1 (fr) * | 1986-07-10 | 1988-01-28 | Toray Industries, Inc. | Procede et sonde de depistage de bacteries dans des echantillons |
| FI883482A7 (fi) * | 1986-11-24 | 1988-07-22 | Gen Probe Inc | Nukleiinihappokoettimia ei-virusperäisten organismien toteamista ja/ta i kvantitatiivista määritystä varten. |
| DE3718591A1 (de) * | 1987-06-03 | 1988-12-15 | Behringwerke Ag | Aeusseres membranprotein f von pseudomonas aeruginosa |
| US5089386A (en) * | 1987-09-11 | 1992-02-18 | Gene-Trak Systems | Test for listeria |
| EP0355147B1 (en) | 1988-01-13 | 1995-04-19 | Institut Pasteur | Dna probe specific for pathogenic listeria |
| ES2058566T3 (es) | 1988-04-15 | 1994-11-01 | Innogenetics Nv | Sondas de hibridacion para detectar las cepas de neisseria. |
| US5523205A (en) * | 1988-08-02 | 1996-06-04 | Institut Pasteur | DNA probes specific for hemolytic listeria |
| US5084565A (en) * | 1988-08-18 | 1992-01-28 | Gene-Trak Systems | Probes for the specific detection of escherichia coli and shigella |
| FR2636075B1 (fr) * | 1988-09-07 | 1991-11-15 | Biotechnologie Ste Europ | Procede de detection des bacteries, levures, parasites et autres eucaryotes, notamment dans les produits alimentaires |
| US5041372A (en) * | 1988-11-02 | 1991-08-20 | The United States Of America As Represented By The Department Of Health And Human Services | Probe to identify enteroinvasive E. coli and Shigella species |
| US5030556A (en) * | 1989-03-30 | 1991-07-09 | Danielle Beaulieu | Species-specific DNNA probe for the detection of Branhamella catarrhalis |
| ATE127529T1 (de) * | 1989-05-23 | 1995-09-15 | Amoco Corp | Nukleinsäuresonden zum nachweis von staphylococcus aureus. |
| WO1990015157A1 (en) * | 1989-05-31 | 1990-12-13 | Gene-Trak Systems | Universal eubacteria nucleic acid probes and methods |
| DE3925613A1 (de) | 1989-06-22 | 1991-01-03 | Boehringer Mannheim Gmbh | Neisseria-spezifische dna-sonde |
| US5334501A (en) * | 1989-07-11 | 1994-08-02 | Microprobe Corporation | Quantification of bacteria using a nucleic acid hybridization assay |
| NL9002157A (nl) * | 1989-11-27 | 1991-06-17 | U Gene Research Bv | Dna fragmenten en daarop gebaseerde dna-probes en primers. |
| CA2033718A1 (en) * | 1990-01-19 | 1991-07-20 | Ronald M. Atlas | Process for detection of water-borne microbial pathogens and indicators of human fecal contamination in water samples and kits therefor |
| WO1991011531A1 (en) * | 1990-02-02 | 1991-08-08 | N.V. Innogenetics S.A. | Hybridization probes for the detection of branhamella catarrhalis strains |
| EP0452596A1 (en) * | 1990-04-18 | 1991-10-23 | N.V. Innogenetics S.A. | Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms |
| SE466259B (sv) * | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| DE69132830T2 (de) * | 1990-10-05 | 2002-07-18 | F. Hoffmann-La Roche Ag, Basel | Verfahren und Reagentien für die Identifikation von Bakterien |
| US5980909A (en) * | 1991-02-15 | 1999-11-09 | Uab Research Foundation | Epitopic regions of pneumococcal surface protein A |
| EP0571538B1 (en) * | 1991-02-15 | 1998-07-08 | The Uab Research Foundation | Structural gene of pneumococcal protein |
| US5472843A (en) * | 1991-04-25 | 1995-12-05 | Gen-Probe Incorporated | Nucleic acid probes to Haemophilus influenzae |
| US5232831A (en) * | 1991-06-28 | 1993-08-03 | Gen-Probe Incorporated | Nucleic acid probes to streptococcus pyogenes |
| NZ243802A (en) * | 1991-07-31 | 1994-12-22 | Hoffmann La Roche | Polynucleotide probes and methods for their use for identifying and detecting bacteria capable of causing meningitis |
| JPH0549477A (ja) * | 1991-08-05 | 1993-03-02 | Wakunaga Pharmaceut Co Ltd | スタフイロコツカス属細菌類の検出 |
| CA2075423A1 (en) * | 1991-08-13 | 1993-02-14 | Paul Luther Skatrud | Rapid method for detection of methicillin resistant staphylococci |
| US5292874A (en) * | 1991-09-04 | 1994-03-08 | Gen-Probe Incorporated | Nucleic acid probes to Staphylococcus aureus |
| FR2685334B1 (fr) * | 1991-12-23 | 1995-05-05 | Bio Merieux | Polypeptides contenant des sequences caracteristiques de pyrrolidone carboxylyl peptidases, polynucleotides contenant une sequence codant pour de tels polypeptides, et leur utilisation. |
| JPH0690798A (ja) * | 1992-02-05 | 1994-04-05 | Toagosei Chem Ind Co Ltd | 黄色ブドウ球菌検出用プローブ及び検出方法 |
| FR2687168B1 (fr) * | 1992-02-10 | 1994-03-25 | Bio Merieux | Fragment de l'adn genomique de streptococcus pneumoniae, sonde d'hybridation, amorce d'amplification, reactif et procede de detection de streptococcus pneumoniae. |
| JPH0654700A (ja) * | 1992-05-19 | 1994-03-01 | Mitsui Toatsu Chem Inc | 耐性菌の高感度検出法 |
| JP2798499B2 (ja) * | 1992-07-07 | 1998-09-17 | 扶桑薬品工業株式会社 | 感染症診断用プローブ |
| IL106273A0 (en) * | 1992-07-17 | 1993-11-15 | Res Dev Foundation | Rapid detection of biopolymers in stained specimens |
| JPH06165681A (ja) * | 1992-12-02 | 1994-06-14 | Toyobo Co Ltd | メチシリン耐性ブドウ球菌検出用オリゴヌクレオチド、メチシリン耐性ブドウ球菌の検出法および検出用試薬キット |
| JP3644961B2 (ja) * | 1993-06-23 | 2005-05-11 | ベックマン コールター インコーポレイテッド | ストレプトコッカス・ピオゲネスから誘導された組換えｄｎアーゼｂ |
| JP3499263B2 (ja) * | 1993-09-03 | 2004-02-23 | 株式会社紀文食品 | クレブシエラ属菌の検出及び塩基配列 |
| US5426026A (en) * | 1993-09-15 | 1995-06-20 | University Of Pittsburgh | PCR identification of four medically important candida species using one primer pair and four species-specific probes |
| US5712118A (en) * | 1993-09-29 | 1998-01-27 | Research Foundation Of State University Of New York | Vaccine for branhamella catarrhalis |
| JP3525475B2 (ja) * | 1994-01-10 | 2004-05-10 | 恵 河野 | 新規な ’ｍｅｃＡタンパク質、それをコードするＤＮＡ、およびそれを用いたメチシリン耐性黄色ブドウ球菌の検出方法 |
| US5582978A (en) * | 1994-01-21 | 1996-12-10 | Amoco Corporation | Nucleic acid probes for the detection of Haemophilus influenzae |
| EP1098006A1 (en) * | 1994-06-24 | 2001-05-09 | Innogenetics N.V. | Simultaneous detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| EP0771352B1 (en) * | 1994-07-19 | 2006-01-11 | Wyeth Holdings Corporation | Nontypable haemophilus influenzae lkp tip adhesin protein and nucleic acid |
| US5668263A (en) * | 1994-12-16 | 1997-09-16 | Smithkline Beecham Corporation | Conserved yeast nucleic acid sequences |
| US5827515A (en) * | 1995-08-30 | 1998-10-27 | Sandoz Ltd. | Bacillus thuringiensis sporulation gene |
| US6737248B2 (en) * | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
-
1996
- 1996-11-04 US US08/743,637 patent/US5994066A/en not_active Expired - Lifetime
-
1997
- 1997-11-04 AU AU48598/97A patent/AU731850B2/en not_active Expired
- 1997-11-04 EP EP09163281A patent/EP2128268B1/en not_active Expired - Lifetime
- 1997-11-04 AT AT97911094T patent/ATE434669T1/de active
- 1997-11-04 EP EP97911094A patent/EP0943009B1/en not_active Expired - Lifetime
- 1997-11-04 EP EP10181608A patent/EP2339034A1/en not_active Withdrawn
- 1997-11-04 CA CA2789369A patent/CA2789369C/en not_active Expired - Lifetime
- 1997-11-04 CA CA2270281A patent/CA2270281C/en not_active Expired - Fee Related
- 1997-11-04 EP EP10184075.9A patent/EP2336366B1/en not_active Expired - Lifetime
- 1997-11-04 NZ NZ335548A patent/NZ335548A/en not_active IP Right Cessation
- 1997-11-04 CN CN97180194A patent/CN1248295A/zh active Pending
- 1997-11-04 ES ES97911094T patent/ES2329202T3/es not_active Expired - Lifetime
- 1997-11-04 WO PCT/CA1997/000829 patent/WO1998020157A2/en not_active Ceased
- 1997-11-04 EP EP10181610.6A patent/EP2336364B1/en not_active Expired - Lifetime
- 1997-11-04 JP JP52090798A patent/JP2001504330A/ja not_active Withdrawn
- 1997-11-04 CA CA2715575A patent/CA2715575C/en not_active Expired - Lifetime
- 1997-11-04 BR BR9713494-5A patent/BR9713494A/pt not_active Application Discontinuation
- 1997-11-04 DE DE69739473T patent/DE69739473D1/de not_active Expired - Lifetime
- 1997-11-04 CA CA2790915A patent/CA2790915C/en not_active Expired - Lifetime
- 1997-11-04 DK DK97911094T patent/DK0943009T3/da active
- 1997-11-04 EP EP10181607.2A patent/EP2345746B1/en not_active Expired - Lifetime
- 1997-11-04 EP EP10181601A patent/EP2339033A1/en not_active Withdrawn
- 1997-11-04 AT AT09163281T patent/ATE552352T1/de active
- 1997-11-04 EP EP10181604.9A patent/EP2336365B1/en not_active Expired - Lifetime
-
1999
- 1999-04-26 NO NO991976A patent/NO991976L/no unknown
-
2008
- 2008-06-18 JP JP2008159646A patent/JP2008289493A/ja active Pending
-
2009
- 2009-12-22 JP JP2009290683A patent/JP5221507B2/ja not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2699539A1 (fr) * | 1992-12-18 | 1994-06-24 | Pasteur Institut | Protéine conférant une résistance de type inductible, à des glycopeptides, notamment chez des bactéries à gram-positif. Séquence de nucléotides codant pour cette protéine. |
| WO1996008582A2 (en) * | 1994-09-12 | 1996-03-21 | Bergeron Michel G | Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9777335B2 (en) | 2001-06-04 | 2017-10-03 | Geneohm Sciences Canada Inc. | Method for the detection and identification of methicillin-resistant Staphylococcus aureus |
| US10577664B2 (en) | 2001-06-04 | 2020-03-03 | Geneohm Sciences Canada, Inc. | Method for the detection and identification of methicillin-resistant Staphylococcus aureus |
| US10801074B2 (en) | 2001-06-04 | 2020-10-13 | Geneohm Sciences Canada, Inc. | Method for the detection and identification of methicillin-resistant Staphylococcus aureus |
| US11834720B2 (en) | 2005-10-11 | 2023-12-05 | Geneohm Sciences, Inc. | Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU731850B2 (en) | Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories | |
| US20030049636A1 (en) | Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories | |
| EP1138786B1 (en) | Specific and universal amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories | |
| US7943346B2 (en) | Probes and primers for detection of bacterial pathogens and antibiotic resistance genes | |
| AU775763B2 (en) | Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories | |
| US6028187A (en) | Nucleic acid probes to Listeria monocytogenes | |
| MXPA99004119A (en) | Specie | |
| AU705198C (en) | Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories | |
| MXPA01006838A (en) | Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |